in a second part a clinical pharmacological study ( single subcutaneous administrations of 100 micrograms and 200 micrograms and multiple 5 day subcutaneous administration of 200 micrograms of mdp-lys ( l18 ) was performed on male healthy volunteers to assess pharmacokinetics , effect on leukocyte function and on immune system , and safety : 1 .
C0023516
leukocyte
C0020962
immune system